HOME >> MEDICINE >> NEWS
Vitamin D supplements should be given to Asian children for two years from birth

Vitamin D supplements should be given to Asian children from birth up to the age of two years, to curb the re-emergence of vitamin D deficiency in the UK , say researchers.

They base their claims on an analysis of cases of vitamin D deficiency between 1994 and 2005, which is published ahead of print in the Archives of Disease in Childhood .

Vitamin D deficiency can cause rickets, poor tooth formation, convulsions, general ill health, and stunted growth. And it has been linked to an increased risk of multiple sclerosis, certain cancers, and cardiovascular disease, diabetes, osteoporosis, and mental health problems in later life.

Increased skin pigmentation makes it more difficult to synthesise the vitamin.

The analysis covers patients at one health trust in north west England , which used to provide vitamin D supplements.

During the period under study, they identified 14 cases of vitamin D deficiency, 12 of which were diagnosed between 2000 and 2005. Virtually all those affected were of Asian ethnicity, and none had received vitamin D supplements.

The figures showed that rates of vitamin D deficiency were around eight times as high among Asian children, with one in 117 affected, compared with one in 923 children, overall.

But in recent years, health authorities have deemed the cost of primary prevention a needless expense, given that the overall levels of vitamin D deficiency in the population are low, say the authors.

Vitamin D supplementation has declined nationwide, with only 4% of babies given the supplement in 2000, compared with 12% so treated in 1995.

This is despite recommendations from the government Committee on Medical Aspects of Food and Nutritional Policy (COMA), which suggest that infants and young children should be given vitamin D supplements for at least the first two years of their lives, and more recent advice from the Chief Medical Officer.

B
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ Specialty Journals
30-Aug-2006


Page: 1 2

Related medicine news :

1. Vitamin D supplements may offer cheap and effective immune system boost against TB
2. Vitamin A deficiency linked to major intestinal surgery
3. Vitamin D and calcium supplements have varied effects on breast cancer risk
4. Vitamin D targets thrombosis in cancer patients
5. Vitamin C depletion correlates with lower body fat, not weight loss during short-term diet
6. Vitamin C and E supplements do not prevent pre-eclampsia in pregnant women at risk
7. Vitamin D inhibits progression of some prostate cancers
8. Vitamin D signals to prevent bone loss during osteoporosis
9. Vitamin D supplementation during pregnancy could reduce osteoporosis in children
10. Vitamin D can play role in lung health
11. Vitamin D status appears more important than high calcium intake for maintaining calcium metabolism

Post Your Comments:
(Date:5/23/2013)... Clinic researchers have used next generation genomic analysis to ... tumors have similar genetic origins, which may help in ... the journal Cancer Research . , "This is ... generation sequencing in adjacent Gleason patterns in the same ... pathology," says ,John Cheville, M.D., Mayo Clinic pathologist and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Dr. Katherine ... new charitable organization in Orange County, OCCares , will ... Orange County. The event details are as follows: , ... Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 , ... crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
(Date:5/23/2013)... New York, NY (PRWEB) May 23, 2013 ... http://bit.ly/Z4m6UI , Canadian tech start-ups are increasingly seeing ... deals with larger US-based companies, according to ... business development engine. , The company has compiled ... entitled Borderless Investments. The findings of the research have ...
(Date:5/23/2013)... 23, 2013 Cheap Concert Tickets announces that ... of 2013 at stadiums throughout North America. This well ... Paul McCartney concert tickets to help McCartney fans see Sir ... Concert Tickets, states that she is also offering the customer ... Being a baby boomer, she is also a huge ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Symptoms of ... psychiatric disorders, complicating diagnosis and treatment. But researchers ... that may be unique to borderline personality disorder: ... face. , , "They have difficulty processing facial ... a neutral face," said Anthony Ruocco, a clinical ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3
(Date:5/23/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") announced today ... Threshold from 90 percent to 50 percent of Maximum ... with the terms of the Revised Offer Document issued ... Under the terms of the Increased Offer, Royalty Pharma ... ) for $12.50 per share in cash. The Increased ...
(Date:5/23/2013)... 23, 2013   BioLife Solutions , Inc. (OTC:BLFS), ... grade hypothermic storage and cryopreservation freeze ... aseptic media manufacturer , today announced its participation at ... Congress 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President ...
(Date:5/23/2013)... PARIS , May 23, 2013 /PRNewswire/ ... developer and manufacturer of precision guided therapy tools designed ... peripheral vascular disease, today announced preliminary results from the ... ndependent S tenosis E valuation) II trial ... at EuroPCR 2013. These prospective results confirm prior retrospective ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
Cached News: